Document:

NEITHER
      THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS
      WARRANT HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
      THE
      SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
      TO
      SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
      COMPANY.

     

    CAMPUSTECH,
      INC.

    

    WARRANT

     

    
      	Warrant No.
              MB-[       ]	
              Date
                of Original Issuance: _________,
                2007      

            

    

     

    CampusTech,
      Inc.,
      a
      Delaware corporation (the “Company”),
      hereby
      certifies that, for value received, ______________________ or its registered
      assigns (the “Holder”),
      is
      entitled to purchase from the Company up to a total number of shares of common
      stock, $0.0001 par value per share (the “Common
      Stock”),
      of the
      Company (each such share, a “Warrant
      Share”
      and all
      such shares, the “Warrant
      Shares”)
      representing 40% of the conversion shares issuable under the _______ shares
      of
      Series A Preferred Stock issued to the Holder in the Series A Preferred Stock
      offering divided by the applicable conversion price under the Series A Preferred
      Stock in effect at the time of exercise at an exercise price per share equal
      to
      the greater of: (i) $2.00 or (ii) if the Company consummates an initial,
      firm commitment underwritten offering of its common stock which generates gross
      proceeds of at least $10 million to the Company (a “Qualified
      IPO”)
      the
      price of common stock issued in the Qualified IPO (the “Exercise
      Price”)
      (as
      adjusted from time to time as provided in Section 9), at any time and from
      time to time from and after the date hereof and through and including three
      (3)
      years from the date of original issuance (the “Expiration
      Date”),
      and
      subject to the following terms and conditions:

     

    1.  Definitions.
      In
      addition to the terms defined elsewhere in this Warrant, capitalized terms
      that
      are not otherwise defined herein shall have the meanings given to such terms
      in
      the Subscription Agreement of even date herewith to which the Company and the
      original Holder are parties (the “Subscription
      Agreement”),
      pursuant to which this Warrant is being issued.

     

    2.  Registration
      of Warrant.
      The
      Company shall register this Warrant, upon records to be maintained by the
      Company for that purpose (the “Warrant
      Register”),
      in the
      name of the record Holder hereof from time to time. The Company may deem and
      treat the registered Holder of this Warrant as the absolute owner hereof for
      the
      purpose of any exercise hereof or any distribution to the Holder, and for all
      other purposes, absent actual notice to the contrary.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    3.  Exchange
      of Warrant and Registration of Transfers.
      This
      Warrant is exchangeable, without expense, at the option of the Holder, upon
      presentation and surrender of this Warrant to the Company for other Warrants
      of
      different denominations entitling the Holder thereof to purchase in the
      aggregate the same number of shares of Common Stock purchasable hereunder.
      This
      Warrant may be divided or combined with other Warrants which carry the same
      rights upon presentation of this Warrant at the office of the Company, together
      with a written notice specifying the names and denominations in which new
      Warrants are to be issued and signed by the Holder hereof. The term “Warrant” as
      used herein includes any Warrants into which this Warrant may be divided or
      for
      which it may be exchanged. The Company shall register the transfer of any
      portion of this Warrant in the Warrant Register, upon surrender of this Warrant,
      with the Form of Assignment attached hereto duly completed and signed, to the
      Company at its address specified herein. Upon any such registration or transfer,
      a new Warrant to purchase Common Stock, in substantially the form of this
      Warrant (any such new Warrant, a “New
      Warrant”),
      evidencing the portion of this Warrant so transferred shall be issued to the
      transferee and a New Warrant evidencing the remaining portion of this Warrant
      not so transferred, if any, shall be issued to the transferring Holder. The
      acceptance of the New Warrant by the transferee thereof shall be deemed the
      acceptance by such transferee of all of the rights and obligations of a holder
      of a Warrant. 

     

    4.  Exercise
      and Duration of Warrants.
      This
      Warrant shall be exercisable, in whole or in part, by the registered Holder
      at
      any time and from time to time on or after the first anniversary of the date
      of
      original issuance, to and including the Expiration Date. At 5:30 p.m., New
      York
      City time on the Expiration Date, the portion of this Warrant not exercised
      prior thereto shall be and become void and of no value.

     

    5.  Delivery
      of Warrant Shares.

     

    (a)  To
      effect
      exercises hereunder, the Holder shall not be required to physically surrender
      this Warrant unless the aggregate Warrant Shares represented by this Warrant
      is
      being exercised. Upon delivery of the attached Exercise Notice to the Company
      (with the attached Warrant Shares Exercise Log) at its address for notice set
      forth herein and upon payment of the Exercise Price multiplied by the number
      of
      Warrant Shares that the Holder intends to purchase hereunder, the Company shall
      promptly (but in no event later than three business days after the Date of
      Exercise (as defined herein)) issue and deliver to the Holder, a certificate
      for
      the duly authorized, validly issued, fully paid and non-assessable Warrant
      Shares issuable upon such exercise, which, unless otherwise required by the
      Subscription Agreement, shall be free of restrictive legends. All issuances
      of
      Warrant Shares pursuant to the exercise of this Warrant shall be rounded (up
      or
      down as the case may be) to the nearest whole share. A “Date
      of Exercise”
means
      the date on which the Holder shall have delivered to the Company: (i) the
      Exercise Notice (with the Warrant Exercise Log attached to it), appropriately
      completed and duly signed and (ii) if such Holder is not utilizing the cashless
      exercise provisions set forth in this Warrant, payment of the Exercise Price
      for
      the number of Warrant Shares so indicated by the Holder to be
      purchased.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    (b)  The
      Company's obligations to issue and deliver Warrant Shares in accordance with
      the
      terms hereof are absolute and unconditional, irrespective of any action or
      inaction by the Holder to enforce the same, any waiver or consent with respect
      to any provision hereof, the recovery of any judgment against any person or
      entity or any action to enforce the same, or any setoff, counterclaim,
      recoupment, limitation or termination, or any breach or alleged breach by the
      Holder or any other person or entity of any obligation to the Company or any
      violation or alleged violation of law by the Holder or any other person or
      entity, and irrespective of any other circumstance which might otherwise limit
      such obligation of the Company to the Holder in connection with the issuance
      of
      Warrant Shares. Nothing herein shall limit a Holder's right to pursue any other
      remedies available to it hereunder, at law or in equity including, without
      limitation, a decree of specific performance and/or injunctive relief with
      respect to the Company's failure to timely deliver certificates representing
      shares of Common Stock upon exercise of the Warrant as required pursuant to
      the
      terms hereof.

     

    6.  Charges,
      Taxes and Expenses.
      Issuance and delivery of certificates for shares of Common Stock upon exercise
      of this Warrant shall be made without charge to the Holder for any issue or
      transfer tax, withholding tax, transfer agent fee or other incidental tax or
      expense in respect of the issuance of such certificates, all of which taxes
      and
      expenses shall be paid by the Company; provided, however, that the Company
      shall
      not be required to pay any tax which may be payable in respect of any transfer
      involved in the registration of any certificates for Warrant Shares or Warrants
      in a name other than that of the Holder. The Holder shall be responsible for
      all
      other tax liability that may arise as a result of holding or transferring this
      Warrant or receiving Warrant Shares upon exercise hereof.

     

    7.  Replacement
      of Warrant.
      If this
      Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or
      cause to be issued in exchange and substitution for and upon cancellation
      hereof, or in lieu of and substitution for this Warrant, a New Warrant, but
      only
      upon receipt of evidence reasonably satisfactory to the Company of such loss,
      theft or destruction and customary and reasonable indemnity (which shall not
      include a surety bond), if requested. Applicants for a New Warrant under such
      circumstances shall also comply with such other reasonable regulations and
      procedures and pay such other reasonable third-party costs as the Company may
      prescribe. Any New Warrant executed and delivered shall constitute a contractual
      obligation on the part of the Company. If a New Warrant is requested as a result
      of a mutilation of this Warrant, then the Holder shall deliver such mutilated
      Warrant to the Company as a condition precedent to the Company’s obligation to
      issue the New Warrant.

     

    8.  Reservation
      of Warrant Shares.
      The
      Company covenants that it will at all times reserve and keep available out
      of
      the aggregate of its authorized but unissued and otherwise unreserved Common
      Stock, solely for the purpose of enabling it to issue Warrant Shares upon
      exercise of this Warrant as herein provided, the number of Warrant Shares which
      are then issuable and deliverable upon the exercise of this entire Warrant,
      free
      from preemptive rights or any other contingent purchase rights of persons other
      than the Holder (taking into account the adjustments and restrictions of
Section
      9).
      The
      Company covenants that all Warrant Shares so issuable and deliverable shall,
      upon issuance and the payment of the applicable Exercise Price in accordance
      with the terms hereof, be duly and validly authorized, issued and fully paid
      and
      nonassessable.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

       

    

    9.  Certain
      Adjustments.
      The
      Exercise Price in effect at any time and number of Warrant Shares issuable
      upon
      exercise of this Warrant are subject to adjustment from time to time as set
      forth in this Section 9.

     

    (a)  Stock
      Dividends and Splits.
      If the
      Company, at any time while this Warrant is outstanding, (i) pays a stock
      dividend on its Common Stock or otherwise makes a distribution on any class
      of
      capital stock that is payable in shares of Common Stock, (ii) subdivides or
      reclassifies outstanding shares of Common Stock into a larger number of shares,
      or (iii) combines or reclassifies outstanding shares of Common Stock into a
      smaller number of shares or otherwise effect a reverse stock split, then in
      each
      such case the Exercise Price shall be multiplied by a fraction of which the
      numerator shall be the number of shares of Common Stock outstanding immediately
      before such event and of which the denominator shall be the number of shares
      of
      Common Stock outstanding immediately after such event. Any adjustment made
      pursuant to clause (i) of this paragraph shall become effective immediately
      after the record date for the determination of stockholders entitled to receive
      such dividend or distribution, and any adjustment pursuant to clause (ii) or
      (iii) of this paragraph shall become effective immediately after the effective
      date of such subdivision or combination. If any event requiring an adjustment
      under this paragraph occurs during the period that an Exercise Price is
      calculated hereunder, then the calculation of such Exercise Price shall be
      adjusted appropriately to reflect such event.

     

    (b)  Fundamental
      Transactions.
      If, at
      any time while this Warrant is outstanding, (1) the Company effects any merger
      or consolidation of the Company with or into another corporation or other
      entity, (2) the Company effects any sale of all or substantially all of its
      assets in one or a series of related transactions, (3) any tender offer or
      exchange offer (whether by the Company or another corporation or other entity)
      is completed pursuant to which holders of Common Stock are permitted to tender
      or exchange their shares for other securities, cash or property, (4) the Company
      effects any reclassification of the Common Stock or any compulsory share
      exchange pursuant to which the Common Stock is effectively converted into or
      exchanged for other securities, cash or property, or (5) the Company takes
      a
      record of its holders of Common Stock for the purpose of entitling them to
      receive any distributions of securities, cash or property (in any such case,
      a
“Fundamental
      Transaction”),
      then
      the Holder shall have the right thereafter to receive, upon exercise of this
      Warrant, the same amount and kind of securities, cash or property as it would
      have been entitled to receive upon the occurrence of such Fundamental
      Transaction if it had been, immediately prior to such Fundamental Transaction,
      the holder of the number of Warrant Shares then issuable upon exercise in full
      of this Warrant (the “Alternate
      Consideration”).
      For
      purposes of any such exercise, the determination of the Exercise Price shall
      be
      appropriately adjusted to apply to such Alternate Consideration based on the
      amount of Alternate Consideration issuable in respect of one share of Common
      Stock in such Fundamental Transaction, and the Company shall apportion the
      Exercise Price among the Alternate Consideration in a reasonable manner
      reflecting the relative value of any different components of the Alternate
      Consideration. If holders of Common Stock are given any choice as to the
      securities, cash or property to be received in a Fundamental Transaction, then
      the Holder shall be given the same choice as to the Alternate Consideration
      it
      receives upon any exercise of this Warrant following such Fundamental
      Transaction. At the Holder's option and request, any successor to the Company
      or
      surviving entity in such Fundamental Transaction shall issue to the Holder
      a new
      warrant substantially in the form of this Warrant and consistent with the
      foregoing provisions and evidencing the Holder's right to purchase the Alternate
      Consideration for the aggregate Exercise Price upon exercise thereof. The terms
      of any agreement pursuant to which a Fundamental Transaction is effected shall
      include terms requiring any such successor or surviving entity to comply with
      the provisions of this paragraph (b) and insuring that the Warrant (or any
      such
      replacement security) will be similarly adjusted upon any subsequent transaction
      analogous to a Fundamental Transaction.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

       

    

    (c)  The
      Company may retain a firm of independent public accountants of recognized
      standing selected by the Board (who may be the regular accountants employed
      by
      the Company) to make any computation required by this Section 9.

     

    (d)  In
      the
      event that at any time, as a result of an adjustment made pursuant to Section
      9(a) or (b) of this Warrant, the Holder of any Warrant thereafter shall become
      entitled to receive any shares of the Company’s capital stock, other than Common
      Stock, thereafter the number of such other shares so receivable upon exercise
      of
      this Warrant shall be subject to adjustment from time to time in a manner and
      on
      terms as nearly equivalent as practicable to the provisions with respect to
      the
      Common Stock contained in Sections 9(a) through (b), inclusive, of this
      Warrant.

     

    (e)  Calculations.
      All
      calculations under this Section 9 shall be made to the nearest cent or the
      nearest 1/100th
      of a
      share, as applicable. The number of shares of Common Stock outstanding at any
      given time shall not include shares owned or held by or for the account of
      the
      Company, and the disposition of any such shares shall be considered an issue
      or
      sale of Common Stock.

     

    (f)  Notice
      of Adjustments.
      Upon
      the occurrence of each adjustment pursuant to this Section 9, the Company at
      its
      expense will promptly compute such adjustment in accordance with the terms
      of
      this Warrant and prepare a certificate setting forth such adjustment, including
      a statement of the adjusted Exercise Price and adjusted number or type of
      Warrant Shares or other securities issuable upon exercise of this Warrant (as
      applicable), describing the transactions giving rise to such adjustments and
      showing in detail the facts upon which such adjustment is based. Upon written
      request, the Company will promptly deliver a copy of each such certificate
      to
      the Holder and to the Company’s Transfer Agent, if any.

     

    (g)  Notice
      of Corporate Events.
      If the
      Company: (i) solicits stockholder approval for any Fundamental Transaction
      or
      (ii) authorizes the voluntary dissolution, liquidation or winding up of the
      affairs of the Company, then the Company shall deliver to the Holder a notice
      describing the material terms and conditions of such transaction, at least
      10
      calendar days prior to the applicable record or effective date on which a person
      or entity would need to hold Common Stock in order to participate in or vote
      with respect to such transaction, and the Company will take all steps reasonably
      necessary in order to insure that the Holder is given the practical opportunity
      to exercise this Warrant prior to such time so as to participate in or vote
      with
      respect to such transaction; provided, however, that the failure to deliver
      such
      notice or any defect therein shall not affect the validity of the corporate
      action required to be described in such notice.

     

    10.  Payment
      of Exercise Price.
      The
      Holder may pay the Exercise Price in one of the following manners:

     

    (a)  Cash
      Exercise.
      The
      Holder may deliver immediately available funds; or

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

       

    

    (b)  Cashless
      Exercise.
      The
      Holder may notify the Company in an Exercise Notice of its election to utilize
      cashless exercise, in which event the Company shall issue to the Holder the
      number of Warrant Shares determined as follows:

     

    X
      = Y
      [(A-B)/A]

     

    where:

     

    X
      = the
      number of Warrant Shares to be issued to the Holder.

     

    Y
      = the
      number of Warrant Shares with respect to which this Warrant is being
      exercised.

     

    A
      = the
“Market Price” (as defined below) of one share of Common Stock as at the date
      the net issue election is made.

     

    B
      = the
      Exercise Price.

     

    For
      purposes of Rule 144 promulgated under the Securities Act, it is intended,
      understood and acknowledged that the Warrant Shares issued in a cashless
      exercise transaction shall be deemed to have been acquired by the Holder, and
      the holding period for the Warrant Shares shall be deemed to have commenced,
      on
      the date this Warrant was originally issued.

     

    11.  No
      Rights as Stockholder.
      Until
      the exercise of this Warrant, the Holder shall not have or exercise any rights
      by virtue hereof as a stockholder of the Company.

     

    12.  No
      Fractional Shares.
      No
      fractional shares of Warrant Shares will be issued in connection with any
      exercise of this Warrant. In lieu of any fractional shares which would,
      otherwise be issuable, the Company shall pay cash equal to the product of such
      fraction multiplied by the Market Price of one Warrant Share on the date of
      exercise. “Market
      Price”
as
      of a
      particular date (the “Valuation
      Date”)
      shall
      mean the following: (a) if the Common Stock are then listed on a U.S. national
      stock exchange, the closing sale price of one share of Common Stock on such
      exchange on the last trading day prior to the Valuation Date; (b) if the Common
      Stock are then quoted on the National Association of Securities Dealers, Inc.
      OTC Bulletin Board (the “Bulletin
      Board”)
      or
      such similar quotation system or association, the closing sale price of one
      share of Common Stock on the Bulletin Board or such other quotation system
      or
      association on the last trading day prior to the Valuation Date or, if no such
      closing sale price is available, the average of the high bid and the low asked
      price quoted thereon on the last trading day prior to the Valuation Date; or
      (c)
      if the Common Stock are not then listed on a national stock exchange or quoted
      on the Bulletin Board or such other quotation system or association, the fair
      market value of one share of Common Stock as of the Valuation Date, as
      determined in good faith by the Board of Directors of the Company and the
      Holder. In the event that the Board of Directors of the Company and the Holder
      are unable to agree upon the fair market value of the Common Stock, the Company
      and the Holder shall jointly select an appraiser, who is experienced in such
      matters. The decision of such appraiser shall be final and conclusive, and
      the
      cost of such appraiser shall be borne equally by the Company and the
      Holder.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

       

    

    13.  Notices.
      Any and
      all notices or other communications or deliveries hereunder (including, without
      limitation, any Exercise Notice) shall be in writing and shall be deemed given
      and effective on the earliest of (i) the date of transmission, if such notice
      or
      communication is delivered via facsimile at the facsimile number specified
      in
      this Section prior to 5:30 p.m. (New York City time) on a business day, (ii)
      the
      next business day after the date of transmission, if such notice or
      communication is delivered via facsimile at the facsimile number specified
      in
      this Section on a day that is not a business day or later than 5:30 p.m. (New
      York City time) on any business day, (iii) the business day following the date
      of mailing, if sent by nationally recognized overnight courier service, or
      (iv)
      upon actual receipt by the party to whom such notice is required to be given.
      The addresses for such communications shall be: (i) if to the Company, to
      CampusTech, Inc., 803 Sycolin Road SE, Suite 204, Leesburg, VA 20175, Attention:
      President, Facsimile No.: 703-777-3871 or such other address as the Company
      shall so notify the Holder, or (ii) if to the Holder, to the address or
      facsimile number appearing on the Warrant Register or such other address or
      facsimile number as the Holder may provide to the Company in accordance with
      this Section.

     

    14.  Warrant
      Agent.
      The
      Company shall serve as warrant agent under this Warrant. Upon 10 days’ notice to
      the Holder, the Company may appoint a new warrant agent. Any corporation into
      which the Company or any new warrant agent may be merged or any corporation
      resulting from any consolidation to which the Company or any new warrant agent
      shall be a party or any corporation to which the Company or any new warrant
      agent transfers substantially all of its corporate trust or shareholders
      services business shall be a successor warrant agent under this Warrant without
      any further act. Any such successor warrant agent shall promptly cause notice
      of
      its succession as warrant agent to be mailed (by first class mail, postage
      prepaid) to the Holder at the Holder's last address as shown on the Warrant
      Register.

     

    15.  Registration
      Rights

     

    The
      Holder shall have registration rights with respect to the Warrant Shares as
      set
forth
      in
      the Subscription Agreement.

    

    16.  Miscellaneous.

     

    (a)  This
      Warrant shall be binding on and inure to the benefit of the parties hereto
      and
      their respective successors and assigns. Subject to the preceding sentence,
      nothing in this Warrant shall be construed to give to any person or entity
      other
      than the Company and the Holder any legal or equitable right, remedy or cause
      of
      action under this Warrant. This Warrant may be amended only in writing signed
      by
      the Company and the Holder and their successors and assigns.

     

    (b)  All
      questions concerning the construction, validity, enforcement and interpretation
      of this Warrant shall be governed by and construed and enforced in accordance
      with the internal laws of the State of New York, without regard to the
      principles of conflicts of law thereof. Each party agrees that all legal
      proceedings concerning the interpretations, enforcement and defense of this
      Warrant and the transactions herein contemplated (“Proceedings”)
      (whether brought against a party hereto or its respective Affiliates, employees
      or agents) may be commenced non-exclusively in the state and federal courts
      sitting in the City of New York, Borough of Manhattan (the “New
      York Courts”).
      Each
      party hereto hereby irrevocably submits to the non-exclusive jurisdiction of
      the
      New York Courts for the adjudication of any dispute hereunder or in connection
      herewith or with any transaction contemplated hereby or discussed herein, and
      hereby irrevocably waives, and agrees not to assert in any Proceeding, any
      claim
      that it is not personally subject to the jurisdiction of any New York Court,
      or
      that such Proceeding has been commenced in an improper or inconvenient forum.
      Each party hereto hereby irrevocably waives personal service of process and
      consents to process being served in any such Proceeding by mailing a copy
      thereof via registered or certified mail or overnight delivery (with evidence
      of
      delivery) to such party at the address in effect for notices to it under this
      Warrant and agrees that such service shall constitute good and sufficient
      service of process and notice thereof. Nothing contained herein shall be deemed
      to limit in any way any right to serve process in any manner permitted by law.
      Each party hereto hereby irrevocably waives, to the fullest extent permitted
      by
      applicable law, any and all right to trial by jury in any legal proceeding
      arising out of or relating to this Warrant or the transactions contemplated
      hereby. If either party shall commence a Proceeding to enforce any provisions
      of
      this Warrant, then the prevailing party in such Proceeding shall be reimbursed
      by the other party for its attorney’s fees and other costs and expenses incurred
      with the investigation, preparation and prosecution of such
      Proceeding.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

       

    

    (c)  The
      headings herein are for convenience only, do not constitute a part of this
      Warrant and shall not be deemed to limit or affect any of the provisions
      hereof.

     

    (d)  In
      case
      any one or more of the provisions of this Warrant shall be invalid or
      unenforceable in any respect, the validity and enforceability of the remaining
      terms and provisions of this Warrant shall not in any way be affected or
      impaired thereby and the parties will attempt in good faith to agree upon a
      valid and enforceable provision which shall be a commercially reasonable
      substitute therefor, and upon so agreeing, shall incorporate such substitute
      provision in this Warrant.

     

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK,

    SIGNATURE
      PAGE FOLLOWS]

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by
      its
      authorized officer as of the date first indicated above. 

     

    
      	 	 	 
	 	
              CAMPUSTECH,
                INC.

            
	 
 	 
 	 
 
	
            	By:  	
            
	 	 	
              
 
	 	Name:   	 
	 	 	
              
 
	 	Title:	 
	 	
              

            

    

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    CAMPUSTECH,
      INC.

    DAte
      of
      ORIGINAL ISSUance: ___________, 2007 

    WARRANT
      NO. MB-[     ]

     

    EXERCISE
      NOTICE

     

    TO
      CAMPUSTECH, INC.:

     

    The
      undersigned hereby irrevocably elects to purchase _____________ shares of Common
      Stock pursuant to the above captioned Warrant, and, if such Holder is not
      utilizing the cashless exercise provisions set forth in the Warrant, encloses
      herewith $________ in cash, certified or official bank check or checks or other
      immediately available funds, which sum represents the aggregate Exercise Price
      (as defined in the Warrant) for the number of shares of Common Stock to which
      this Exercise Notice relates, together with any applicable taxes payable by
      the
      undersigned pursuant to the Warrant.

     

    By
      its
      delivery of this Exercise Notice, the undersigned represents and warrants to
      the
      Company that:

     

    
      (a)  Investment
        Intent.
        The
        undersigned is acquiring the Common Stock as principal for its own account
        for
        investment purposes only and not with a view to or for distributing or reselling
        such Common Stock or any part thereof, without prejudice, however, to such
        undersigned’s right at all times to sell or otherwise dispose of all or any part
        of such Common Stock in compliance with applicable federal and state securities
        laws. Subject to the immediately preceding sentence, nothing contained herein
        shall be deemed a representation or warranty by the undersigned to hold the
        Common Stock for any period of time. The undersigned is acquiring the Common
        Stock hereunder in the ordinary course of its business. The undersigned does
        not
        have any agreement or understanding, directly or indirectly, with any person
        to
        distribute any of the Common Stock. Notwithstanding the foregoing, nothing
        herein shall prevent the undersigned from transferring the Common Stock issuable
        upon exercise of this Warrant.

    

     

    
      (b)  Investor
        Status.
        At the
        date hereof the undersigned is, an “accredited investor” as defined in Rule
        501(a) under the Securities Act. The undersigned is not a registered
        broker-dealer under Section 15 of the Exchange Act.

    

     

    The
      undersigned requests that certificates for the shares of Common Stock issuable
      upon this exercise be issued in the name of:

     

    PLEASE
      INSERT: 

     

    SOCIAL
      SECURITY OR TAX IDENTIFICATION NO.: ________________________

     

    NAME
      AND
      ADDRESS: _______________________________________________

       
      _______________________________________________

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    Warrant
      Shares Exercise Log

     

    
      	
              Date

            	 	
              Number
                of Warrant Shares Available to be Exercised

            	 	
              Number
                of Warrant Shares Exercised

            	 	
              Number
                of Warrant Shares Remaining to be Exercised

            
	 	 	 	 	 	 	 

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    CAMPUSTECH,
      INC.

    DAte
      of
      ORIGINAL ISSUance: ___________, 2007 

    WARRANT
      NO. MB-[     ]

     

    FORM
      OF
      ASSIGNMENT

     

    [To
      be
      completed and signed only upon transfer of Warrant]

     

    FOR
      VALUE
      RECEIVED, the undersigned hereby sells, assigns and transfers unto
      ________________________________ the right represented by the above-captioned
      Warrant to purchase ____________ shares of Common Stock to which such Warrant
      relates and appoints ________________ attorney to transfer said right on the
      books of the Company with full power of substitution in the
      premises.

     

    Dated: _______________,
      ____

     

    
      	 	 	 	 
	
            	 	 	
              
                

              

              (Signature must conform in all respects to name
                of

              holder as specified on the face of the
                Warrant)

            
	
            	 	 	
            
	 	 	 	 
	 	 	 	
              
                

              

              Address of Transferee

            
	 	 	 	 
	 	 	 	
              
 
	 	 	 	
              
 

    

    In
      the
      presence of:Unassociated Document

    SUBSCRIPTION
      AGREEMENT

    

    This
      Subscription Agreement dated as of May 3, 2007 (the “Agreement”)
      is
      entered into by and among CampusTech, Inc., a Delaware corporation (the
“Company”),
      and
      the individuals and entities listed on Exhibit A
      hereto
      (the “Purchasers”).

    

    BACKGROUND

    

    WHEREAS,
      the Company is offering on a “best efforts/minimum maximum” basis in a private
      placement to “accredited investors” (as such term in defined in Regulation D
      (“Regulation
      D”)
      promulgated under the Securities Act of 1933, as amended (the “Securities
      Act”))
      a
      minimum of $1,000,000 (the “Minimum
      Amount”)
      and up
      to $4,500,000 (the “Maximum
      Amount”)
      of
      units (the “Units”),
      each
      Unit consisting of: (i) one $10,000 face value one-year 8% senior convertible
      debenture of the Company (the “Convertible
      Debenture”),
      in
      the form attached hereto at Exhibit B,
      and
      (ii) a three-year warrant (the “Warrant”)
      to
      purchase a number of shares of the Company’s common stock, $0.0001 par value per
      share (the “Common
      Stock”),
      representing 40% of the $10,000 face value of the Convertible Debenture divided
      by the applicable conversion price in effect at the time of exercise, in the
      form attached hereto at Exhibit C
      (the
“Offering”);
      and

    

    WHEREAS,
      each Purchaser desires to purchase that number of Units set forth on the
      signature page hereof, in the minimum investment amount of $10,000, on the
      terms
      and conditions hereinafter set forth and on the terms and conditions set forth
      herein.

     

    NOW,
      THEREFORE, in consideration of the premises and the mutual representations
      and
      covenants hereinafter set forth, the parties hereto agree as
      follows:

    

    1. Authorization
      and Sale of Units.

    

    1.1 Authorization.
      The
      Company has, or before the Initial Closing (as defined in Section 2) will
      have, duly authorized the sale and issuance, pursuant to the terms of this
      Agreement, of up to 450 Units comprising an aggregate of $4,500,000 in
      Convertible Debentures and up to 1,800,000 Warrants.

    

    1.2 Sale
      of Units; Subscription for Units.
      Subject
      to the terms and conditions of this Agreement, at the applicable Closing, the
      Company will sell and issue to each of the Purchasers, and each of the
      Purchasers will purchase the number of Units set forth opposite such Purchaser’s
      name on Exhibit A
      for the
      purchase price of $10,000 per Unit and for the aggregate subscription amount
      set
      forth on the signature page hereto. The Convertible Debentures, the Warrants
      and
      the shares of common stock issuable upon the exercise of the Warrants being
      sold
      under this Agreement are sometimes hereinafter collectively referred to as
      the
“Securities.”
The
      Company’s agreement with each of the Purchasers is a separate agreement, and the
      sale of Units to each of the Purchasers is a separate sale.

     

    To
      subscribe for Units, this Agreement must be properly completed, executed and,
      prior to the Company’s receipt of subscriptions representing the Minimum Amount,
      the purchase price delivered to American Stock Transfer & Trust Company (the
“Escrow
      Agent”),
      59
      Maiden Lane, New York, New York 10038. A Purchaser desiring to deliver the
      purchase price for the Units in the form of wire transfer shall wire to the
      Escrow Agent at:
      Bank Name: JP
      MORGAN
      CHASE BANK, ABA
      #: 021
      000
      021, Acct
      #: 323-113109,
      Acct.
      Name: AMERICAN
      STOCK TRANSFER & TRUST COMPANY AS AGENT FOR CAMPUS TECH, INC.
      If the
      purchase price is paid by wire transfer, the Purchaser shall: (i) include the
      Purchaser's name in the wire transfer instructions; and (ii) request from the
      bank or other financial institution that is originating the transfer the federal
      wire number with respect to the wire and retain that number for future
      reference. If a subscription is not accepted, whether in whole or in part,
      the
      subscription funds held by the Escrow Agent will be returned to the investor
      without interest or deduction. 

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    1.3 Use
      of
      Proceeds.
      The
      Company will use the net proceeds from the sale of the Units as set forth in
      the
      Memorandum (hereinafter defined).

    

    2. The
      Closing.
      

    

    (a) Subject
      to the terms and conditions set forth in this Agreement, the initial closing
      shall occur on the sale by the Company of at least the Minimum Amount under
      this
      Agreement and shall take place at such time and place as the Company and Maxim
      Group LLC, as placement agent (“Maxim”)
      may
      designate (the “Initial Closing,”
and
      the date on which the Initial Closing occurs, the “Initial
      Closing Date”).
      Following the Initial Closing Date, and up to May 31, 2007 (the “Termination
      Date”),
      the
      Company may hold additional closings (each, with the Initial Closing, a
“Closing”,
      and
      each such date, with the Initial Closing Date, a “Closing
      Date”)
      until
      the earlier of: (i) such time as the Company has sold up to the Maximum Amount
      or (ii) the Termination Date. The Termination Date shall be subject to extension
      by agreement between the Company and Maxim for up to an additional 30 days
      without notice to investors. Each Purchaser acknowledges that no assurances
      can
      be given that either the Minimum Amount or the Maximum Amount will be
      sold.

    

    (b) At
      or
      prior to the Closing, the Company shall deliver or cause to be delivered to
      each
      Purchaser the following (the “Company
      Deliverables”):

    

    (i) copies
      of
      the executed instruments evidencing the Convertible Debenture and Warrants
      being
      purchased by such Purchaser, registered in the name of such
      Purchaser;

    

    (ii) this
      Agreement duly executed by the Company;

    

    (iii) a
      certificate, executed by an authorized officer of the Company and dated as
      of
      the Closing Date in the form previously provided on or prior to the date hereof
      by counsel to the Purchasers; and

    

    (iv) the
      legal
      opinion of counsel for the Company addressed to the Purchasers in form and
      substance reasonably satisfactory to counsel to the Purchasers.

    

    (c) At
      or
      prior to the Closing, each Purchaser shall deliver or cause to be delivered
      the
      following (the “Purchaser
      Deliverables”):

    

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

       

    

    (i) the
      payment of the aggregate purchase price for the Units by check or wire transfer,
      as specified in Exhibit
      A,
      delivered to the Escrow Agent;

    

    (ii) this
      Agreement duly executed by such Purchaser and delivered to the
      Company.

    

    The
      parties hereto acknowledge and agree that the Company Deliverables and the
      Purchaser Deliverables may be delivered prior to the Closing via facsimile
      or
      other electronic copy and shall be held in escrow by the parties hereto until
      Closing. Promptly following the applicable Closing, the Company shall deliver
      to
      each of the Purchasers an original instrument evidencing the Convertible
      Debenture and Warrants being purchased by such Purchaser, registered in the
      name
      of such Purchaser. Each Purchaser hereby authorizes and directs the Company
      to
      deliver the Securities to be issued to the Purchaser pursuant to this Agreement
      directly to the residential or business address indicated on the signature
      page
      hereto or to Maxim on behalf of such Purchaser.

    

    3. Representations
      of the Purchasers.
      Each of
      the Purchasers severally represents and warrants to the Company as
      follows:

    

    (a) The
      Purchaser has received and carefully reviewed a copy of the confidential private
      placement memorandum relating to the Securities (the “Memorandum”)
      and
      any amendments or supplements thereto, has carefully considered the risk factors
      discussed in the “Risk Factors” section and has had the opportunity to obtain
      any additional information or documentation necessary to verify the information
      contained in such documents.

    

    (b) The
      Purchaser has had a reasonable opportunity to ask questions of and receive
      answers from the Company concerning the Company and the Offering, and all such
      questions, if any, have been answered to the full satisfaction of the Purchaser.
      

    

    (c) The
      Purchaser understands that the Company has determined that the exemption from
      the registration provisions of the Securities Act provided by Regulation D
      is
      applicable to the offer and sale of the Securities, based, in part, upon the
      representations, warranties and agreements made by the Purchaser
      herein.

    

    (d) Except
      as
      set forth herein, no representations or warranties have been made to the
      Purchaser by the Company or any agent, employee or affiliate of the Company
      and
      in entering into this transaction, the Purchaser is not relying upon any
      information other than the results of independent investigation by the
      Purchaser.

    

    (e) The
      Purchaser has full power and authority to execute and deliver this Agreement
      and
      to perform the obligations of the Purchaser hereunder and this Agreement is
      a
      legally binding obligation of the Purchaser enforceable in accordance with
      its
      terms and subject to laws of general application relating to bankruptcy,
      insolvency and the relief of debtors and rules of law governing specific
      performance, injunctive relief or other general principals of equity, whether
      such enforcement is considered in a proceeding in equity or law.

    

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

       

      (f)
        Regulation D.

    

    (i) The
      Purchaser understands and acknowledges that: (A) the Securities acquired
      pursuant to this Agreement have not been registered under the Securities Act
      and
      are being sold in reliance upon an exemption from registration afforded by
      Regulation D; and that such Securities have not been registered with any
      state securities commission or authority; (B) pursuant to the requirements
      of
      Regulation D, the Securities may not be transferred, sold or otherwise
      exchanged unless in compliance with the provisions of Regulation D and/or
      pursuant to registration under the Securities Act, or pursuant to an available
      exemption thereunder; and (C) other than as set forth in Section 5.1 of this
      Agreement, the Company is under no obligation to register the Securities under
      the Securities Act or any state securities law, or to take any action to make
      any exemption from any such registration provisions available.

    

       (ii) The
      Purchaser is an “accredited investor” within the meaning of Rule 501 of
      Regulation D, is knowledgeable, sophisticated and experienced in making, and
      is
      qualified to make, decisions with respect to investment shares representing
      an
      investment decision like that involved in the purchase of the
      Securities.

    

    (iii) The
      Purchaser is purchasing the Securities for his, her or its own account for
      investment only and has no present intention of selling or distributing the
      Securities and no other person has any interest in or participation in the
      Securities or any right, option, security interest, pledge or other interest
      in
      or to the Securities. The Purchaser recognizes that an investment in the
      Securities involves a high degree of risk, including a risk of total loss of
      the
      Purchaser. The Purchaser understands, acknowledges and agrees that it must
      bear
      the economic risk of its investment in the Securities for an indefinite period
      of time and has knowledge and experience in financial and business matters
      such
      that it is capable of evaluating the risks of the investment in the Securities
      and the Purchaser understands, acknowledges and agrees that prior to any such
      offer or sale, the Company may require, subject to the fulfillment of the
      Company’s obligations under Section 6 of this Agreement, as a condition to
      effecting a transfer of the Securities, an opinion of counsel, acceptable to
      the
      Company, as to the registration or exemption therefrom under the Securities
      Act
      and any state securities acts, if applicable.

    

    (iv) The
      Purchaser acknowledges that the Securities will bear a legend in substantially
      the following form:

    

    THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN
      REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)
      OR ANY STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
      PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
      PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
      THE
      REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY. THE SECURITIES ALSO ARE SUBJECT TO A LOCK-UP
      AGREEMENT BETWEEN THE HOLDER AND MAXIM GROUP LLC.

    

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

       

    

    (g)  Neither
      the Purchaser, nor
      any
      affiliate of the Purchaser or any person acting on his, her or its behalf,
      has
      recently sold shares of unregistered Common Stock of the Company.

    

    (h)  The
      Purchaser
      has
      carefully considered and has discussed with the Purchaser’s
      professional legal, tax, accounting and financial advisors, to the extent
the
      Purchaser
      has
      deemed necessary, the suitability of this investment and the transactions
      contemplated by this Subscription Agreement for the
      Purchaser’s
      particular federal, state, local and foreign tax and financial situation and
      has
      determined that this investment and the transactions contemplated by this
      Subscription Agreement are suitable for the
      Purchaser.
      The
      Purchaser
      relies
      solely on such advisors and not on any statements or representations of the
      Company or any of its agents. The
      Purchaser
      understands that the
      Purchaser
      (and not
      the Company) shall be responsible for the
      Purchaser’s
      own
      tax liability that may arise as a result of this investment or the transactions
      contemplated by this Subscription Agreement.

    

    (i)  The
      information provided by the
      Purchaser
      in the
      Confidential Purchaser Questionnaire accompanying this Subscription Agreement
      is
      true and correct.

    

    4. Covenants,
      Representations and Warranties of the Company.
      The
      Company covenants with, represents and warrants to, the Purchasers as
      follows:

    

    (a) The
      Company and its Controlled Subsidiaries, are (a) corporations duly organized,
      validly existing and in good standing under the laws of their respective states
      of incorporation, each have full power and authority to own or lease all of
      the
      assets owned or leased by each of them and to conduct their respective business
      as described in the Memorandum and (b) are duly qualified to do business and
      in
      good standing as a foreign corporation in all jurisdictions in which the nature
      of the activities conducted or the character of the assets owned or leased
      makes
      such qualification necessary, except where the failure to be so qualified would
      not have a material adverse effect on the Company's presently conducted business
      taken as a whole with the business of the Controlled Subsidiaries (“Material
      Adverse Effect”).
      The
      term “Controlled Subsidiaries” means any corporation or other organization in
      which the Company owns, directly or indirectly, an equity or other ownership
      interest equal to or greater than 50 percent.

    

    (b) The
      Company has all such corporate power and authority to enter into, deliver and
      perform this Agreement.

    

    (c) All
      necessary corporate action has been duly and validly taken by the Company to
      authorize the execution, delivery and performance of this Agreement by the
      Company, and the issuance and sale of the Securities to be sold by the Company
      pursuant to this Agreement. This Agreement has been duly and validly authorized,
      executed and delivered by the Company and constitutes the legal, valid and
      binding obligation of the Company enforceable against the Company in accordance
      with its terms, except as the enforceability thereof may be limited by
      bankruptcy, insolvency, reorganization, moratorium or other similar laws
      affecting the enforcement of creditors’ rights generally and by general
      equitable principles.

    

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

       

    

    (d)  The
      execution, delivery and performance of this Agreement, and all other documents
      to be entered into by the Company in connection with any transaction described
      in the Memorandum or in connection with the Offering, and the consummation
      of
      the transactions contemplated hereby and thereby, have been or will be prior
      to
      such execution, delivery, performance or consummation, as the case may be,
      duly
      and validly authorized by the Company and do not and will not: (i) constitute,
      or result in, a breach or violation of any of the terms, provisions or
      conditions of the certificate of incorporation or by-laws of the Company (ii)
      constitute, or result in, a material violation of any applicable statute, law,
      ordinance or regulation of any state, territory or other jurisdiction, or (iii)
      violate, constitute, or result in, a default under (or an event which with
      the
      passing of time or the giving of notice or both would constitute a default
      under) or breach of the terms, provisions or conditions of any material
      indenture, note, contract, commitment, instrument or document to which the
      Company is or will be a party or by which the Company, or any of its properties
      are bound, or any award, judgment, decree, rule or regulation of any court
      or
      governmental or regulatory agency or body having jurisdiction over the Company
      or its respective activities or properties except, in the cases of clauses
      (ii)
      and (iii), where such defaults or violations do not, individually or in the
      aggregate, have a Material Adverse Effect.

    

    (e)  The
      Memorandum and/or information provided by the Company to the Purchaser do not
      contain any untrue statement of a material fact or omit to state any material
      fact required to be stated therein or necessary to make the statements therein
      not misleading.

    

    (f)  As
      of the
      date hereof there is no litigation, arbitration, claim, governmental or other
      proceeding (formal or informal), or investigation pending or to the Company's
      knowledge threatened, with respect to the Company or its Controlled
      Subsidiaries, or their respective operations, businesses, properties, or assets,
      except as properly described in the Memorandum or such as individually or in
      the
      aggregate do not now have and will not in the future have a material adverse
      effect upon the operations, business, properties, or assets of the Company
      or
      its Controlled Subsidiaries. To the Company's knowledge, neither the Company
      nor
      its Controlled Subsidiaries are, nor as of each Closing Date shall be, in
      violation of, or in default with respect to, any law, rule, regulation, order,
      judgment, or decree, except as properly described in the Memorandum or such
      as
      individually or in the aggregate do not have and will not in the future have
      a
      material adverse effect upon the operations, business, properties, or assets
      of
      the Company; nor is the Company required to take any action in order to avoid
      any such violation or default.

    

    (g)  To
      the
      best of its knowledge, neither the Company nor its Controlled Subsidiaries
      have
      infringed, are not infringing, and has not received notice of infringement
      with
      respect to asserted intangibles of others. To the best knowledge of the Company,
      none of the patents, patent applications, trademarks, service marks, trade
      names
      and copyrights, and licenses and rights to the foregoing presently owned or
      held
      by the Company, materially infringe upon any like right of any other person
      or
      entity. The Company: (i) owns or has the right to use, free and clear of all
      liens, charges, claims, encumbrances, pledges, security interests, defects
      or
      other restrictions of any kind whatsoever, sufficient patents, trademarks,
      service marks, trade names, copyrights, licenses and right with respect to
      the
      foregoing, to conduct its business as presently conducted except as set forth
      in
      the Memorandum, and (ii) except as set forth in the Memorandum, is not obligated
      or under any liability whatsoever to make any payments by way of royalties,
      fees
      or otherwise to any owner or licensee of, or other claimant to, any patent,
      trademark, service mark, trade name, copyright, know-how, technology or other
      intangible asset, with respect to the use thereof or in connection with the
      conduct of its business as now conducted or otherwise. The Company and its
      Controlled Subsidiaries has direct ownership of title to all their intellectual
      property (including all United States and foreign patent applications and
      patents), other proprietary rights, confidential information and know-how;
      owns
      all the rights to their Intangibles as are currently used in or have potential
      for use in their business.

    

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

       

    

    (h)  The
      Convertible Debenture (including the shares of Common Stock thereunder) and
      Warrants (and the shares of Common Stock thereunder) to be issued and sold
      to
      the undersigned as provided in the Memorandum have been duly authorized and
      when
      issued and delivered against payment therefor, will be validly issued, fully
      paid and non-assessable and will conform to the description thereof in the
      Memorandum. The Warrants are exercisable for Common Stock and the shares of
      Common Stock issuable upon exercise of the Warrants have been duly authorized
      and when issued and delivered upon exercise and due payment therefor will be
      validly issued, fully paid and non-assessable and will conform to the
      description thereof in the Memorandum; and there are no preemptive or other
      rights to subscribe for or to purchase, nor any restriction upon the voting
      or
      transfer of, any shares of the Common Stock issuable upon exercise of the
      Warrants pursuant to the Company's certificate of incorporation or by-laws
      or
      any agreement or other outstanding instrument to which the Company is a party
      or
      is otherwise known to the Company. The Company has reserved sufficient shares
      of
      Common Stock to be issued upon conversion or exercise of the Convertible
      Debentures or the Warrants. Subject to the accuracy of the representations
      and
      warranties of the Purchasers in this Agreement, the offer and issuance by the
      Company of the Securities is exempt from registration under the Securities
      Act.

    

    (i)  The
      Company shall provide for the transfer, upon request of the Purchaser, or
      removal of any legends upon the Securities, all as may be allowed in accordance
      with SEC Rule 144, and provide any required opinions of counsel to the Company’s
      transfer agents, at no cost to the Purchaser. The Company shall make generally
      available such information as may be necessary under SEC Rule 144 to allow
      for
      the resale of Securities by the Purchaser.

    

    (j)  The
      outstanding options, warrants and other convertible securities of the Company
      are as set forth in the Memorandum.
      Except
      as set forth in the Memorandum, neither the Company nor any subsidiary is a
      party to an agreement, instrument or understanding which calls for, and no
      securities of the Company or any of its Controlled Subsidiaries contain
      provisions relating to, the
      resetting or repricing
      of any debt or equity security instrument of the Company or any of its
      Controlled Subsidiaries. The issuance of the Securities or the consummation
      of
      the Offering will not trigger any resetting or repricing of any debt or equity
      security instrument of the Company or any of its Controlled Subsidiaries and,
      except as set forth in the Memorandum, will not result in any preemptive rights
      to acquire securities of the Company in favor of any third party.

    

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

       

    

    (k)  Neither
      the Company nor any of its Controlled Subsidiaries are (i) in violation of
      its
      certificate of incorporation or by-laws, (ii) to the best knowledge of the
      Company, in violation of any statute, law, rule, code, administrative
      regulation, ordinance, judgment, order or decree of any government, governmental
      instrumentality, court, domestic or foreign, or arbitration panel or other
      body
      applicable to it where such violation would have a material adverse effect
      or
      (iii) to the best knowledge of the Company, in default in the performance or
      observance of any obligation, agreement, covenant or condition contained in
      any
      indenture, mortgage, deed of trust, voting agreement, voting trust agreement,
      loan agreement, bond, debenture, note or other evidence of indebtedness, lease,
      sublease, license agreement, contract or other agreement or instrument to which
      it is a party or by which it or any of its respective properties are bound
      or
      affected (“contracts”), where such defaults, singly or in the aggregate, would
      have a Material Adverse Effect. To the actual knowledge of the Company, no
      other
      party under any contract is in default in any material respect thereunder which
      affects the Company or any subsidiary.

    

    (l)  The
      Company and its Controlled Subsidiaries: (i) has paid all federal, state, local
      and foreign taxes for which it is liable and has furnished all information
      returns it is required to furnish pursuant to the Internal Revenue Code of
      1986,
      as amended, (ii) has established adequate reserves for such taxes which are
      not
      due and payable and (iii) does not have any tax deficiency or claims
      outstanding, proposed or assessed against it.

    

    5. Covenants
      and Agreements of the Company.
      

    

    5.1 Mandatory
      Registration.
      Subject
      to the rights of holders of Company registration rights as disclosed on the
      Memorandum, concurrently with any initial, underwritten, public offering by
      the
      Company of Common Stock with gross proceeds to the Company exceeding $10,000,000
      (a “Qualifying
      IPO”),
      the
      Company shall include all Registrable Shares (as defined below) in the
      Registration Statement filed with the Securities and Exchange Commission (the
      “Commission”)
      in
      connection with the Qualifying IPO. 

    

    5.2 Piggyback
      Registration Rights.
      Subject
      to the rights of holders of Company registration rights as disclosed on the
      Memorandum, if at any time the Company shall determine to register under the
      Securities Act any of its securities (other than on Form S-1, Form S-8 or Form
      S-4 or their then equivalents and other than shares to be issued solely: (i)
      in
      connection with a Qualifying IPO, (ii) any acquisition of any entity or business
      (iii) upon the exercise of stock options, or (iv) pursuant to employee benefit
      plans), it shall send to each holder of Registrable Shares (as defined below),
      including each holder who has the right to acquire Registrable Shares, written
      notice of such determination and, if within twenty (20) days after receipt
      of
      such notice, such holder shall so request in writing, the Company shall use
      its
      commercially reasonable efforts to include in such Registration Statement all
      or
      any part of the Registrable Shares such holder requests to be registered
      therein; provided that, if, in connection with any offering involving an
      underwriting of Common Stock to be issued by the Company, the managing
      underwriter shall prohibit the inclusion of shares of Common Stock by selling
      holders in such Registration Statement or shall impose a limitation on the
      number of shares of such Common Stock which may be included in any such
      Registration Statement because, in its judgment, such limitation is necessary
      to
      effect an orderly public distribution, the Company shall then be obligated
      to
      include in such Registration Statement only such limited portion (which may
      be
      none) of the Registrable Shares with respect to which such holder has requested
      inclusion hereunder. 

    

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

       

    

    The
      term
“Effectiveness
      Period”
means
      the period beginning on the date of effectiveness of the Registration Statement
      and ending the date which is the earlier date of when: (i) all Registrable
      Shares have been sold (other than in a private transaction) or (ii) all
      Registrable Shares covered by such Registration Statement may be sold
      immediately without registration under the Securities Act and without volume
      restrictions pursuant to Rule 144(k), as determined by the counsel to the
      Company pursuant to a written opinion letter to such effect, addressed and
      reasonably acceptable to the Company’s transfer agent and the affected
      Purchasers.

     

    The
      term
“Prospectus”
means
      the prospectus included in the Registration Statement (including, without
      limitation, a prospectus that includes any information previously omitted from
      a
      prospectus filed as part of an effective registration statement in reliance
      upon
      Rule 430A promulgated under the Securities Act), as amended or supplemented
      by
      any prospectus supplement, with respect to the terms of the offering of any
      portion of the Registrable Shares covered by the Registration Statement, and
      all
      other amendments and supplements to the Prospectus, including post-effective
      amendments, and all material incorporated by reference or deemed to be
      incorporated by reference in such Prospectus.

     

    The
      term
“Registration
      Statement”
means
      each registration statement required to be filed hereunder, including the
      Prospectus therein, amendments and supplements to such registration statement
      or
      Prospectus, including pre- and post-effective amendments, all exhibits thereto,
      and all material incorporated by reference or deemed to be incorporated by
      reference in such registration statement.

    

    The
      term
“Registrable
      Shares”
means
      the shares of Common Stock underlying the Convertible Debentures included in
      the
      Units and the shares of Common Stock underlying the Warrants included in the
      Units; provided, however, that shares of Common Stock shall cease to be
      Registrable Shares upon any sale of such shares pursuant to: (i) a registration
      statement filed under the Securities Act, or (ii) Rule 144 promulgated under
      the
      Securities Act.

    

    5.3 Registration
      Procedures. If and whenever the Company is required by the provisions hereof
      to
      effect the registration of any Registrable Shares under the Securities Act,
      the
      Company shall:

     

    (a)  (i)
      prepare and file with the Commission (electronically on EDGAR) a Registration
      Statement covering the resale of the Registrable Shares; (ii) prepare and file
      with the Commission such amendments, including post-effective amendments, to
      the
      Registration Statement as may be necessary to keep the Registration Statement
      continuously effective as to the Registrable Shares for the Effectiveness
      Period; (iii) cause the related Prospectus to be amended or supplemented by
      any
      required Prospectus supplement, and as so supplemented or amended to be properly
      filed; (iv) respond as promptly as reasonably possible to any comments received
      from the Commission with respect to the Registration Statement or any amendment
      thereto; and (v) provide the Purchasers, as promptly as reasonably possible,
      true and complete copies of all correspondence and filings from and to the
      Commission relating to the Registration Statement;

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

       

    

    (b)  furnish
      to the Purchasers, without charge, such number of copies of the Registration
      Statement and the Prospectus included therein (including each preliminary
      Prospectus) as they reasonably may request to facilitate the public sale or
      disposition of the Registrable Shares covered by the Registration
      Statement;

     

    (c)  use
      commercially reasonable efforts to avoid the issuance of or, if issued, obtain
      the withdrawal of: (i) any order suspending the effectiveness of the
      Registration Statement or (ii) any suspension of the qualification (or exemption
      from qualification) of any of the Registrable Shares for sale in any
      jurisdiction, at the earliest practicable moment.

     

    (d)
       use
      its
      commercially reasonable efforts to register or qualify the Registrable Shares
      covered by such Registration Statement under the securities or “blue sky” laws
      of such jurisdictions within the United States as the Purchasers may request,
      provided, however, that the Company shall not for any such purpose be required
      to qualify generally to transact business as a foreign corporation in any
      jurisdiction where it is not so qualified or to consent to general service
      of
      process in any such jurisdiction;

     

    (e)  (i)
      in
      the time and manner required by the trading market or system on which the
      Company is currently listed, prepare and file any additional shares listing
      application covering all of the Registrable Shares; (ii) use commercially
      reasonable efforts, regardless of listing or similar costs, to take all steps
      necessary to cause such Registrable Shares to be approved for listing on such
      trading market or system as soon as possible thereafter; and (iii) use
      commercially reasonable efforts, regardless of listing or similar costs, to
      maintain the listing of such Registrable Shares on such trading market or
      system;

     

    (f)  notify
      the Purchasers as promptly as possible (i) when the Commission notifies the
      Company whether there will be a “review” of a Registration Statement and
      whenever the Commission comments in writing on such Registration Statement;
      and
      (ii) when a Registration Statement, or any post-effective amendment or
      supplement thereto, has become effective, and after the effectiveness thereof:
      (A) of any request by the Commission or any other federal or state governmental
      authority for amendments or supplements to the Registration Statement or
      Prospectus or for additional information; (B) of the issuance by the Commission
      or any state securities commission of any stop order suspending the
      effectiveness of the Registration Statement covering any or all of the
      Registrable Shares or the initiation of any proceedings for that purpose; (C
      )
      of a pending proceeding against the Company under Section 8A of the Securities
      Act in connection with the offering of the Registrable Shares; and (D) of the
      receipt by the Company of any notification with respect to the suspension of
      the
      qualification or exemption from qualification of any of the Registrable Shares
      for sale in any jurisdiction, or the initiation or threatening of any proceeding
      for such purpose. Without limitation of any remedies to which the Purchasers
      may
      be entitled under this Agreement, if any of the events described in Section
      5.3(f)(ii)(A), 5.3(f)(ii)(B), and 5.3(f)(ii)(C) occur, the Company shall use
      its
      reasonable best efforts to respond to and correct the event; 

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

       

    

    (g)  immediately
      notify the Purchasers at any time when a Prospectus relating thereto is required
      to be delivered under the Securities Act, of the happening of any event of
      which
      the Company has knowledge as a result of which the Prospectus contained in
      such
      Registration Statement, as then in effect, includes an untrue statement of
      a
      material fact or omits to state a material fact required to be stated therein
      or
      necessary to make the statements therein not misleading in light of the
      circumstances then existing; and 

     

    (h)  upon
      the
      occurrence of any event described in Section 5.3(g) hereof, as promptly as
      possible, prepare a supplement or amendment, including a post-effective
      amendment, to the Registration Statement or a supplement to the related
      Prospectus or any document incorporated or deemed to be incorporated therein
      by
      reference, and file any other required document so that, as thereafter
      delivered, neither the Registration Statement nor such Prospectus will contain
      an untrue statement of a material fact or omit to state a material fact required
      to be stated therein or necessary to make the statements therein, in light
      of
      the circumstances under which they are made, not misleading. 

    

    5.4 Registration
      Expenses.
      All
      expenses relating to the Company’s compliance with Sections 5.3 hereof,
      including, without limitation, all registration and filing fees, printing
      expenses, fees and disbursements of counsel and independent public accountants
      for the Company, fees and expenses (including reasonable counsel fees) incurred
      in connection with complying with state securities or “blue sky” laws, fees of
      the NASD, transfer taxes, fees of transfer agents and registrars, and reasonable
      fees of, and disbursements incurred by, one counsel for the Purchasers approved
      in advance by the Company, are called “Registration
      Expenses.”
The
      Company shall only be responsible for all Registration Expenses.

    

    5.5 Indemnification.
      (a) In
      the event of a registration of any Registrable Shares under the Securities
      Act
      pursuant to this Agreement, the Company will indemnify and hold harmless each
      Purchaser, and their respective officers, directors, successors and assigns
      and
      each other person, if any, who controls such Purchaser, if any, within the
      meaning of the Securities Act, against any losses, claims, damages or
      liabilities, joint or several, to which such Purchaser, or such persons may
      become subject under the Securities Act or otherwise, insofar as such losses,
      claims, damages or liabilities (or actions in respect thereof) arise out of
      or
      are based upon any untrue statement or alleged untrue statement of any material
      fact contained in any Registration Statement under which such Registrable Shares
      were registered under the Securities Act pursuant to this Agreement, any
      preliminary Prospectus or final Prospectus contained therein, or any amendment
      or supplement thereof, or arise out of or are based upon the omission or alleged
      omission of the Company to state therein a material fact required to be stated
      therein or necessary to make the statements therein not misleading, and will
      reimburse each Purchaser, and each such person for any reasonable legal or
      other
      expenses incurred by them in connection with investigating or defending any
      such
      loss, claim, damage, liability or action; provided, however, that the Company
      will not be liable in any such case if and to the extent that any such loss,
      claim, damage or liability arises out of or is based upon an untrue statement
      or
      alleged untrue statement or omission or alleged omission so made in conformity
      with information furnished by or on behalf of such Purchaser or any such person
      in writing specifically for use in any such document, or the failure of such
      Purchaser to deliver a Prospectus, to the extent that such Purchaser was
      required to do so under applicable securities laws.

    

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

       

    

    (b) Promptly
      after receipt by a party entitled to claim indemnification hereunder (an
“Indemnified
      Party”)
      of
      notice of the commencement of any action, such Indemnified Party shall, if
      a
      claim for indemnification in respect thereof is to be made against a party
      hereto obligated to indemnify such Indemnified Party (an “Indemnifying
      Party”),
      notify the Indemnifying Party in writing thereof, but the omission so to notify
      the Indemnifying Party shall not relieve it from any liability which it may
      have
      to such Indemnified Party other than under this Section 5.5 and shall only
      relieve it from any liability which it may have to such Indemnified Party under
      this Section 5.5 if and to the extent the Indemnifying Party is prejudiced
      by
      such omission. In case any such action shall be brought against any Indemnified
      Party and it shall notify the Indemnifying Party of the commencement thereof,
      the Indemnifying Party shall be entitled to participate in and, to the extent
      it
      shall wish, to assume and undertake the defense thereof with counsel
      satisfactory to such Indemnified Party, and, after notice from the Indemnifying
      Party to such Indemnified Party of its election so to assume and undertake
      the
      defense thereof, the Indemnifying Party shall not be liable to such Indemnified
      Party under this Section 5.5 for any legal expenses subsequently incurred by
      such Indemnified Party in connection with the defense thereof; if the
      Indemnified Party retains its own counsel, then the Indemnified Party shall
      pay
      all fees, costs and expenses of such counsel, provided,
      however,
      that,
      if the defendants in any such action include both the Indemnified Party and
      the
      Indemnifying Party and the Indemnified Party shall have reasonably concluded
      that there may be reasonable defenses available to it which are different from
      or additional to those available to the Indemnifying Party or if the interests
      of the Indemnified Party reasonably may be deemed to conflict with the interests
      of the Indemnifying Party, the Indemnified Party shall have the right to select
      one separate counsel and to assume such legal defenses and otherwise to
      participate in the defense of such action, with the reasonable expenses and
      fees
      of such separate counsel and other expenses related to such participation to
      be
      reimbursed by the Indemnifying Party as incurred.

    

    In
      order
      to provide for just and equitable contribution in the event of joint liability
      under the Securities Act in any case in which either: (i) any Purchaser, or
      any
      officer, director, successor, assign or controlling person of such Purchaser,
      makes a claim for indemnification pursuant to this Section 5.5 but it is
      judicially determined (by the entry of a final judgment or decree by a court
      of
      competent jurisdiction and the expiration of time to appeal or the denial of
      the
      last right of appeal) that such indemnification may not be enforced in such
      case
      notwithstanding the fact that this Section 5.5 provides for indemnification
      in
      such case, or (ii) contribution under the Securities Act may be required on
      the
      part of such Purchaser or such officer, director, successor, assign or
      controlling person of such Purchaser in circumstances for which indemnification
      is provided under this Section 5.5; then, and in each such case, the Company
      and
      such Purchaser will contribute to the aggregate losses, claims, damages or
      liabilities to which they may be subject (after contribution from others) in
      such proportion so that such Purchaser is responsible only for the portion
      represented by the percentage that the public offering price of its securities
      offered by the Registration Statement bears to the public offering price of
      all
      securities offered by such Registration Statement; provided, however, that,
      in
      any such case, (A) such Purchaser will not be required to contribute any amount
      in excess of the public offering price of all such securities offered by it
      pursuant to such Registration Statement; and (B) no person or entity guilty
      of
      fraudulent misrepresentation (within the meaning of Section 10(f) of the Act)
      will be entitled to contribution from any person or entity who was not guilty
      of
      such fraudulent misrepresentation.

    

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

       

    

    5.6 Reservation
      of Common Stock.
      The
      Company shall reserve and maintain a sufficient number of shares of Common
      Stock
      for issuance upon exercise of all of the outstanding Securities. 

    

    5.7 Information
      Rights.
      Until
      the consummation of an initial public offering of the Company’s Common Stock,
      the Company shall provide to the Purchasers within 120 days following the end
      of
      the Company’s fiscal year (i) audited financial statements of the Company, and
      (ii) a copy of the auditor’s letter to management relating to such financial
      statements.

    

    6. Transfer
      of Securities.
      The
      Purchaser is aware that the Company will make a notation in its appropriate
      records and issue “stop transfer” instructions to its transfer agent with
      respect to the restrictions on the transferability of such
      Securities.

    

    (a) The
      Purchaser understands that this subscription is not binding upon the Company
      until the Company accepts it, which acceptance is at the sole discretion of
      the
      Company and is to be evidenced by the Company’s execution of this Agreement
      where indicated. This Agreement shall be null and void if the Company does
      not
      accept it as aforesaid. In the event the Company does not accept the Offering
      proceeds, the Offering will not be completed and all Offering proceeds will
      thereafter be promptly returned to the Purchasers without interest or deduction.
      The undersigned understands that the Company may, in its sole discretion, reject
      this subscription, in whole or in part, and/or reduce this subscription in
      any
      amount and to any extent, whether or not pro rata reductions are made of any
      other investor’s subscription.

    

    (b) Subject
      to applicable state securities laws, the subscription delivered to the Company
      by the Purchaser pursuant to this Agreement is not subject to revocation by
      the
      Purchaser, but may be rejected by the Company, in whole or in part, in the
      Company’s sole discretion, in which event the purchase price and execution copy
      of this Agreement submitted will be returned (by mail) to the undersigned
      without interest or deduction within 15 business days thereafter. 

     

    7. Conditions
      Precedent to Closing.
      

    

    (a) The
      obligation of each Purchaser to acquire the Units at the Closing is subject
      to
      the receipt by such Purchaser at or before the Closing of the Company
      Deliverables in accordance with Section 2(b).

    

    (b) The
      obligation of the Company to sell the Units at the Closing is subject to the
      receipt by the Company at or before the Closing of the Purchaser Deliverables
      in
      accordance with Section 2(c).

    

    8. Lock-Up
      Arrangements.
      Notwithstanding anything herein to the contrary, the Purchaser agrees that
      such
      Purchaser shall not, for a period commencing on the date of the final prospectus
      relating to a Qualifying IPO, pursuant to an effective registration statement
      under the Securities Act covering the offer and sale of Common Stock for the
      account of the Company and ending six (6) months thereafter (the “Lock-Up
      Period”)
      directly or indirectly, offer, sell, agree to offer or sell, solicit offers
      to
      purchase, grant any call option or purchase any put option with respect to,
      pledge, borrow or otherwise dispose of any Securities or the shares of Common
      Stock underlying such Securities (the “Relevant
      Securities”).
      Any
      waiver of the Lock-Up Period granted to any of the Purchasers, or waiver of
      any
      lock-up period to less than a period of six (6) months by which any of the
      officers, directors or stockholders of the Company are bound, shall be made
      on a
      pro rata basis to all of the Purchasers. Notwithstanding the foregoing, and
      subject to the conditions below, the Purchaser may transfer the Relevant
      Securities in the transactions described in clauses (i) through (vi) below,
      provided that (1) the Company receives a signed lock-up agreement for the
      balance of the lock-up period from each donee, trustee, distributee, or
      transferee, as the case may be, (2) any such transfer shall not involve a
      disposition for value, (3) such transfers are not required to be reported in
      any
      public report or filing with the Securities and Exchange Commission, or
      otherwise during the Lock-Up Period and (4) the Purchaser does not otherwise
      voluntarily effect any public filing or report regarding such transfers during
      the Lock-Up Period:

    

    
      	(i)  	
              as
                a bona fide gift or gifts; or

            

    

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

       

    

    
      	(ii)  	
              to
                any trust for the direct or indirect benefit of the Purchaser or
                the
                immediate family of the Purchaser;
                or

            

    

     

    
      	(iii)  	
              as
                a distribution to members,
                partners or stockholders of the
                Purchaser;

            

    

     

    
      	(iv)  	
              to
                the Purchaser’s affiliates or to any investment fund or other entity
                controlled or managed by the Purchaser, provided that such affiliate,
                investment fund or other entity controlled or managed by the Purchaser
                shall not be formed for the sole purpose of transferring, for value
                or
                otherwise, the Relevant Securities;
                or

            

    

     

    
      	(v)  	
              to
                any beneficiary of the Purchaser pursuant to a will or other testamentary
                document or applicable laws of descent;
                or

            

    

     

    
      	(vi)  	
              to
                any corporation, partnership, limited liability company or other
                entity
                all of the beneficial ownership interests of which are held by the
                Purchaser or immediate family of the
                Purchaser.

            

    

     

    For
      purposes of this Section, “immediate family” shall mean any relationship by
      blood, marriage or adoption, not more remote than first cousin.

     

    9. Miscellaneous.
      

    

    9.1 Successors
      and Assigns.
      This
      Agreement shall be binding upon and inure to the benefit of the parties and
      their successors and permitted assigns. Any Purchaser may assign any or all
      of
      its rights under this Agreement to any person or entity to whom such Purchaser
      assigns or transfers any Securities, provided such assignee or transferee agrees
      in writing to be bound, with respect to the assigned or transferred Securities,
      by the provisions hereof that apply to the “Purchasers,” in which event such
      assignee or transferee shall be deemed to be a Purchaser hereunder with respect
      to such assigned rights.

    

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

       

    

    9.2 Survival.
      All
      representations and warranties and all covenants, agreements and obligations
      made by the Company or the Purchasers in this Agreement, or in any instrument
      or
      document furnished in connection with this Agreement or the transactions
      contemplated hereby, shall survive the Closing and any investigation at any
      time
      made by or on behalf of any indemnified party. 

    

    9.3. Indemnification.
      The
      Purchaser agrees to indemnify and hold harmless the Company, Maxim, and their
      respective officers, directors, employees, shareholders, agents representatives
      and affiliates, and any person acting on behalf of the Company or Maxim, from
      and against any and all damage, loss, liability, cost and expense (including
      reasonable attorneys’ fees) which any of them may incur by reason of the failure
      by the Purchasers to fulfill any of the terms and conditions of this Agreement,
      or by reason of any breach of the representations and warranties made by the
      Purchasers herein, or in any other document provided by the Purchasers to the
      Company. All representations, warranties and covenants of each of the Purchasers
      and the Company contained herein shall survive the acceptance of this
      subscription.

    

    9.4 Notices.
      All
      notices or other communications hereunder shall be in writing and shall be
      deemed to have been duly given if delivered personally or mailed by certified
      or
      registered mail, return receipt requested, postage prepaid, as follows:

    

    (a) If
      to the
      Company, to CampusTech, Inc., 803 Sycolin Road SE, Suite 204, Leesburg, VA
      20175, Attention: President, or to such other address as the Company shall
      have
      designated to the other by like notice.

    

    (b)
      If
      to a
      Purchaser, at his, her or its address set forth on Exhibit A,
      or
at
      such
      other address or addresses as may have been furnished to the Company in writing
      by such Purchaser with a copy (which shall not constitute notice) to Maxim
      Group
      LLC, 405 Lexington Avenue, New York, NY 10174, Attn: Gregory Leschenko.

    

    9.5 Entire
      Agreement.
      This
      Agreement, the Convertible Debenture and the Warrant embody the entire agreement
      and understanding between the parties hereto with respect to the subject matter
      hereof and supersede all prior agreements and understandings relating to such
      subject matter. 

    

    9.6 Amendments
      and Waivers.
      Except
      as otherwise expressly set forth in this Agreement, any term of this Agreement
      may be amended and the observance of any term of this Agreement may be waived
      (either generally or in a particular instance and either retroactively or
      prospectively) with the written consent of the Company and the majority of
      the
      Purchasers. No waivers of or exceptions to any term, condition or provision
      of
      this Agreement, in any one or more instances, shall be deemed to be, or
      construed as, a further or continuing waiver of any such term, condition or
      provision. 

    

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

       

    

    9.7 Counterparts.
      This
      Agreement may be executed in one or more counterparts, each of which shall
      be
      deemed to be an original, but all of which shall be one and the same document.
      

    

    9.8 Section
      Headings.
      The
      section headings are for the convenience of the parties and in no way alter,
      modify, amend, limit, or restrict the contractual obligations of the parties.
      

    

    9.9 Severability.
      The
      invalidity or unenforceability of any provision of this Agreement shall not
      affect the validity or enforceability of any other provision of this
      Agreement.

    

    9.10 Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of New York. Any legal suit, action or proceeding arising out of or
      relating to this Agreement or the transactions contemplated hereby shall be
      instituted exclusively in New York, New York, or in the United States District
      Court for the Southern District of New York (the “New York Courts”). The parties
      hereto hereby: (i) waives any objection which they may now have or hereafter
      have to the venue of any such suit, action or proceeding, and (ii) irrevocably
      consents to the jurisdiction of the New York Courts in any such suit, action
      or
      proceeding. The parties further agree to accept and acknowledge service of
      any
      and all process which may be served in any such suit, action or proceeding
      in
      the New York Courts and agree that service of process upon a party mailed by
      certified mail to such party’s address shall be deemed in every respect
      effective service of process upon such party in any such suit, action or
      proceeding.

     

    [signature
      page to follow]

    

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

    SIGNATURE
      PAGE

     

    Date
      Signed: _______________________, 2007

    

    Number
      of Units: _____________

    

    Multiplied
      by Offering Price Per Unit:   x    
      $         

    

    Equals
      Amount ($10,000
      minimum):                 =    
      $             
 

     

    
      	 	 	 	 
	
              
Signature	 	 	
              
                

              

              Second Signature

              (if purchasing jointly)

            
	
            	 	 	
            
	 	 	 	 
	
              
                

              

              Printed Name

            	 	 	
              
Printed
              Second Name
	 	 	 	 
	 	 	 	 
	
              
Entity
              Name	 	 	
              
Entity
              Name
	 	 	 	 
	 	 	 	 
	
              
Address	 	 	
              
Address
	 	 	 	 
	 	 	 	 
	
              
City,
              State and Zip Code	 	 	
              
City,
              State and Zip Code
	 	 	 	 
	 	 	 	 
	
              
Telephone-Business	 	 	
              
Telephone-Business
	 	 	 	 
	 	 	 	 
	
              
Facsimile-Business	 	 	
              
Facsimile-Business
	 	 	 	 
	 	 	 	 
	
              
Tax
              ID # or Social Security #	 	 	
              
Tax
              ID # or Social Security
              #

    

     

    Name
      in
      which securities should be issued: ____________________________________

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    ACCEPTANCE
      OF SUBSCRIPTION

     

    This
      Agreement is agreed to and accepted as of May 3, 2007.

    
      	 	 	 
	 	
              CAMPUSTECH,
                INC.

            
	 
 	 
 	 
 
	
            	By:  	
            
	 	
              
Name:
              Michael Faber
	 	
              Title: Executive
                Chairman & Chairman of the
                Board

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]